Literature DB >> 23231038

Berberine and its derivatives: a patent review (2009 - 2012).

Inder Pal Singh1, Shivani Mahajan.   

Abstract

INTRODUCTION: Berberine, a protoberberine alkaloid, and its derivatives exhibit a wide spectrum of pharmacological activities. It has been used in traditional Chinese medicine and Ayurvedic medicine and current research evidences support its use for various therapeutic areas. AREAS COVERED: This review covers the patents on therapeutic activities of berberine and its derivatives in the years between 2009 and 2012. An extensive search was done to collect the patent information using European Patent Office database and SciFinder. The therapeutic areas covered include cancer, inflammation, infectious diseases, cardiovascular, metabolic disorders, and miscellaneous areas such as polycystic ovary syndrome, allergic diseases, and so on. EXPERT OPINION: Berberine along with its derivatives or in combination with other pharmaceutically active compounds or in the form of formulations has applications in various therapeutic areas such as cancer, inflammation, diabetes, depression, hypertension, and various infectious areas. Berberine has demonstrated wide physiological functions and has great potential to give a multipotent drug if some inherent problems on poor bioavailability and solubility are taken care of. Additionally, polyherbal formulations with berberine-containing plants as major ingredients can be successfully developed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23231038     DOI: 10.1517/13543776.2013.746314

Source DB:  PubMed          Journal:  Expert Opin Ther Pat        ISSN: 1354-3776            Impact factor:   6.674


  37 in total

1.  Berberine enhances radiosensitivity of esophageal squamous cancer by targeting HIF-1α in vitro and in vivo.

Authors:  Xi Yang; Baixia Yang; Jing Cai; Chi Zhang; Qu Zhang; Liping Xu; Qin Qin; Hongcheng Zhu; Jianxin Ma; Guangzhou Tao; Hongyan Cheng; Xinchen Sun
Journal:  Cancer Biol Ther       Date:  2013-09-12       Impact factor: 4.742

2.  Glycoside hydrolase family 18 and 20 enzymes are novel targets of the traditional medicine berberine.

Authors:  Yanwei Duan; Tian Liu; Yong Zhou; Tongyi Dou; Qing Yang
Journal:  J Biol Chem       Date:  2018-08-22       Impact factor: 5.157

3.  Berberine inhibits the LPS-induced proliferation and inflammatory response of stromal cells of adenomyosis tissues mediated by the LPS/TLR4 signaling pathway.

Authors:  Li Liu; Li Chen; Caixia Jiang; Jing Guo; Yan Xie; Le Kang; Zhongping Cheng
Journal:  Exp Ther Med       Date:  2017-10-16       Impact factor: 2.447

4.  Fabrication, characterization and optimization of berberine-loaded PLA nanoparticles using coaxial electrospray for sustained drug release.

Authors:  Reza Ghaffarzadegan; Sepideh Khoee; Shamsali Rezazadeh
Journal:  Daru       Date:  2020-04-20       Impact factor: 3.117

5.  Variability in Potency Among Commercial Preparations of Berberine.

Authors:  Ryan S Funk; Rakesh K Singh; Robert D Winefield; Sylvie E Kandel; Janelle F Ruisinger; Patrick M Moriarty; James M Backes
Journal:  J Diet Suppl       Date:  2017-08-09

6.  The neuroprotective effect of berberine in mercury-induced neurotoxicity in rats.

Authors:  Ahmed E Abdel Moneim
Journal:  Metab Brain Dis       Date:  2015-01-21       Impact factor: 3.584

7.  Neuroprotective Potential of Berberine Against Doxorubicin-Induced Toxicity in Rat's Brain.

Authors:  Ghadha Ibrahim Fouad; Kawkab A Ahmed
Journal:  Neurochem Res       Date:  2021-08-17       Impact factor: 3.996

8.  Berberine hydrochloride inhibits cell proliferation and promotes apoptosis of non-small cell lung cancer via the suppression of the MMP2 and Bcl-2/Bax signaling pathways.

Authors:  Jie Li; Fang Liu; Shulong Jiang; Jie Liu; Xiuhong Chen; Shangnuan Zhang; Haibo Zhao
Journal:  Oncol Lett       Date:  2018-03-13       Impact factor: 2.967

9.  Effect of topical berberine in murine cutaneous leishmaniasis lesions.

Authors:  Alba Calvo; Esther Moreno; Irati Aldalur; Carmen Sanmartín; Esther Larrea; Elena González-Peñas; Juan Manuel Irache; Socorro Espuelas
Journal:  J Antimicrob Chemother       Date:  2022-03-31       Impact factor: 5.790

Review 10.  Application of berberine on treating type 2 diabetes mellitus.

Authors:  Bing Pang; Lin-Hua Zhao; Qiang Zhou; Tian-Yu Zhao; Han Wang; Cheng-Juan Gu; Xiao-Lin Tong
Journal:  Int J Endocrinol       Date:  2015-03-11       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.